Literature DB >> 19882246

BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.

Julia J Gorski1, Colin R James, Jennifer E Quinn, Gail E Stewart, Kieran Crosbie Staunton, Niamh E Buckley, Fionnuala A McDyer, Richard D Kennedy, Richard H Wilson, Paul B Mullan, D Paul Harkin.   

Abstract

Expression profiling of BRCA1-deficient tumours has identified a pattern of gene expression similar to basal-like breast tumours. In this study, we examine whether a BRCA1-dependent transcriptional mechanism may underpin the link between BRCA1 and basal-like phenotype. In methods section, the mRNA and protein were harvested from a number of BRCA1 mutant and wild-type breast cancer cell lines and from matched isogenic controls. Microarray-based expression profiling was used to identify potential BRCA1-regulated transcripts. These gene targets were then validated (by in silico analysis of tumour samples) by real-time PCR and Western blot analysis. Chromatin immunoprecipitation (ChIP) assays were used to confirm recruitment of BRCA1 to specific promoters. In results, we demonstrate that functional BRCA1 represses the expression of cytokeratins 5(KRT5) and 17(KRT17) and p-Cadherin (CDH3) in HCC1937 and T47D breast cancer cell lines at both mRNA and protein level. ChIP assays demonstrate that BRCA1 is recruited to the promoters of KRT5, KRT17 and CDH3, and re-ChIP assays confirm that BRCA1 is recruited independently to form c-Myc and Sp1 complexes on the CDH3 promoter. We show that siRNA-mediated inhibition of endogenous c-Myc (and not Sp1) results in a marked increase in CDH3 expression analogous to that observed following the inhibition of endogenous BRCA1. The data provided suggest a model whereby BRCA1 and c-Myc form a repressor complex on the promoters of specific basal genes and represent a potential mechanism to explain the observed overexpression of key basal markers in BRCA1-deficient tumours.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19882246     DOI: 10.1007/s10549-009-0565-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  33 in total

1.  Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer.

Authors:  Ke-Da Yu; Zhi-Ming Shao
Journal:  Nat Rev Cancer       Date:  2012-05-24       Impact factor: 60.716

Review 2.  DNA transcription and repair: a confluence.

Authors:  Robb E Moses; Bert W O'Malley
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

Review 3.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

4.  Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.

Authors:  Marc Warmoes; Janneke E Jaspers; Thang V Pham; Sander R Piersma; Gideon Oudgenoeg; Maarten P G Massink; Quinten Waisfisz; Sven Rottenberg; Epie Boven; Jos Jonkers; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2012-02-24       Impact factor: 5.911

Review 5.  The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.

Authors:  Gemma Molyneux; Matthew J Smalley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-02-19       Impact factor: 2.673

6.  BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function.

Authors:  E Kumaraswamy; K L Wendt; L A Augustine; S R Stecklein; E C Sibala; D Li; S Gunewardena; R A Jensen
Journal:  Oncogene       Date:  2014-11-24       Impact factor: 9.867

7.  Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.

Authors:  Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-25       Impact factor: 4.254

8.  CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells.

Authors:  Sungmin Baek; Yong-Whan Lee; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2010-06-30

9.  Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.

Authors:  Andrea Sau; Rosanna Lau; Miguel A Cabrita; Emma Nolan; Peter A Crooks; Jane E Visvader; M A Christine Pratt
Journal:  Cell Stem Cell       Date:  2016-06-09       Impact factor: 24.633

10.  Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Mol Biol Rep       Date:  2012-11-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.